Malin

82 results

Life sciences company Malin is focused on four priority assets. Photograph: iStock

Troubled UK asset manager Woodford Investment Management sold its remaining 3.5 per cent stake in Irish life sciences company Malin this week, accordi(...)

Neil Woodford, known as  the ‘Oracle from Oxford. Photograph: Richard Cannon

For long-suffering investors in Irish life-sciences investment company Malin, having once-revered UK stock picker Neil Woodford in their corner helped(...)

Malin chief executive Darragh Lyons said this month he expected a ‘resolution to the Woodford situation’. Photograph: iStock

Embattled UK asset manager Woodford Investment Management sold most of its 23 per cent stake in Irish life sciences investment company Malin Corp on T(...)

Malin was the subject of a board and management overhaul in the middle of last year that led to a refocusing of its disparate portfolio of investments around four priority assets

Irish life sciences investment company Malin Corp, whose shares have plunged in recent months amid fears over the future of embattled Woodford Investm(...)

Photograph: iStock

Life sciences investment company Malin Corp said on Tuesday that its chief business and financial officer Darragh Lyons has been appointed group chief(...)

Gary Kennedy, co-chair of the Balance for Better Business review group: ‘The clock is ticking.’   Photograph: Leah Farrell/RollingNews.ie

At least a dozen companies trading on the Euronext Dublin are set to fall short of a Government-backed target for there to be no all-male boards among(...)

Banking shares were out of sorts, with Bank of Ireland down 1.9%, Permanent TSB off 1.6% and AIB slipping 0.7%

European shares saw their week-long rally come to a halt on Wednesday, driven by weakness across oil companies and banks, as soft Chinese economic dat(...)

Neil Woodford CBE, the  British fund manager and the founding partner of Woodford Investment Management. Photograph: Richard Cannon

One of the UK’s best-known fund managers, Neil Woodford, has moved to block investors taking money out of his flagship fund, sending shares in many of(...)

Kymab’s main product is a potential treatment for eczema that is going through clinical trials. Photograph: iStock

One of Dublin-listed life science investment company Malin’s key holdings has signalled it plans to float on the stock market in the US. Biopharmaceu(...)

Ian Curley is a veteran of both Ardagh and Smurfit Kappa. Photograph: Dara Mac Dónaill

Life sciences investment company Malin’s chairman of less than a year, Ian Curley, has signalled that he plans to step down from the board as the busi(...)

  • « First
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »